(Q39838078)

English

Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patients.

scientific article

Statements

Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patients (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit